| Arun-angelo Patil, MD | |
|
2900 Elk Ln, Fremont, NE 68025-8691 | |
| (888) 209-0305 | |
| (952) 442-3620 |
| Full Name | Arun-angelo Patil |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 54 Years |
| Location | 2900 Elk Ln, Fremont, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285684563 | NPI | - | NPPES |
| 47078557581 | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 17562 (Nebraska) | Primary |
| Entity Name | Millard Emergency Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912568999 PECOS PAC ID: 4486051422 Enrollment ID: O20210917002493 |
News Archive
Thought leaders from the medical, scientific and patient advocacy communities gathered in New York and London for CSL Behring's Key Issues Dialogue–Immunoglobulin to examine challenges facing patients with primary immunodeficiencies.
Two new studies reveal that the United States Preventative Services Task Force's recommendation to no longer screen women ages 40-49 for breast cancer using mammograms has begun to negatively affect the number of yearly mammograms performed in this age group and thus decrease the benefits of early detection.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
He is well-qualified to make the many crucial decisions surrounding Medicare and Medicaid, and could end up being one of the most significant appointees in the administration (5/17).
Melbourne researcher, Professor Sam Berkovic, has been awarded the prestigious Zulch Prize from the Max Planck Society in Germany in recognition of his groundbreaking investigations into the genetic foundations of epilepsy.
› Verified 4 days ago
| Entity Name | Papillion Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346822178 PECOS PAC ID: 1759789951 Enrollment ID: O20211001000820 |
News Archive
Thought leaders from the medical, scientific and patient advocacy communities gathered in New York and London for CSL Behring's Key Issues Dialogue–Immunoglobulin to examine challenges facing patients with primary immunodeficiencies.
Two new studies reveal that the United States Preventative Services Task Force's recommendation to no longer screen women ages 40-49 for breast cancer using mammograms has begun to negatively affect the number of yearly mammograms performed in this age group and thus decrease the benefits of early detection.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
He is well-qualified to make the many crucial decisions surrounding Medicare and Medicaid, and could end up being one of the most significant appointees in the administration (5/17).
Melbourne researcher, Professor Sam Berkovic, has been awarded the prestigious Zulch Prize from the Max Planck Society in Germany in recognition of his groundbreaking investigations into the genetic foundations of epilepsy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Arun-angelo Patil, MD 400 10th St E, Waconia, MN 55387-4552 Ph: (888) 209-0305 | Arun-angelo Patil, MD 2900 Elk Ln, Fremont, NE 68025-8691 Ph: (888) 209-0305 |
News Archive
Thought leaders from the medical, scientific and patient advocacy communities gathered in New York and London for CSL Behring's Key Issues Dialogue–Immunoglobulin to examine challenges facing patients with primary immunodeficiencies.
Two new studies reveal that the United States Preventative Services Task Force's recommendation to no longer screen women ages 40-49 for breast cancer using mammograms has begun to negatively affect the number of yearly mammograms performed in this age group and thus decrease the benefits of early detection.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced nationwide availability of the Prosigna™ Breast Cancer Prognostic Gene Signature Assay beginning in the first quarter of 2014.
He is well-qualified to make the many crucial decisions surrounding Medicare and Medicaid, and could end up being one of the most significant appointees in the administration (5/17).
Melbourne researcher, Professor Sam Berkovic, has been awarded the prestigious Zulch Prize from the Max Planck Society in Germany in recognition of his groundbreaking investigations into the genetic foundations of epilepsy.
› Verified 4 days ago